Skip to main content
Scilex Holding Co logo

Scilex Holding Co — Investor Relations & Filings

Ticker · SCLX ISIN · US80880W2052 LEI · 529900SPEA2C7YTTYP45 US Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2023-04-18 Capital/Financing Update
Country US United States of America
Listing US SCLX

About Scilex Holding Co

https://www.scilexholding.com/

Scilex Holding Co. is a company focused on the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company's portfolio targets indications with high unmet medical needs and features therapies with proprietary drug delivery systems. These systems include an advanced topical patch technology for optimized drug delivery through the skin, an anti-inflammatory oral solution designed for individualized dosing in high-risk patients, and a liquid ready-to-use analgesic for migraine relief. Scilex aims to provide effective alternatives to opioid medications to improve patient quality of life.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2023
Capital/Financing Update Classification · 95% confidence The document is a letter from Scilex Holding Company to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-1. It references the Securities Act of 1933 and the Securities Exchange Act of 1934, and specifically mentions the Registration Statement on Form S-1 filed on April 10, 2023. The content is a formal request related to a capital raising process, not a report of financial results or other types of filings. The document length is short (1972 characters) and it is a correspondence related to a capital market transaction. Therefore, the document fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as registration statements and their effectiveness.
2023-04-18 English
Regulatory Filings 2023
Regulatory Filings
2023-04-17 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes detailed information about the Annual Meeting of Stockholders, including postponement notice, voting instructions, proposals to be voted on, and proxy card details. The content is focused on soliciting votes and providing information to shareholders for the upcoming Annual Meeting. It is not the Annual Report, nor an earnings release or other financial report. It is not a simple announcement but the actual proxy solicitation materials. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (over 14,000 characters) and detailed content confirm it is the proxy statement itself, not just an announcement or a brief notice.
2023-04-15 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, detailing the issuance and sale of convertible debentures by Scilex Holding Company, including terms of the debentures, closings, and related agreements. It references securities registration, financing transactions, and material definitive agreements related to capital raising. The document is not a full financial report but an update on financing activities and material agreements. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about financing terms, not just an announcement or a brief notice, confirming it is a substantive filing about capital activities.
2023-04-11 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC by Scilex Holding Company. It details the issuance of a second convertible debenture, including terms of the debenture, the related securities purchase agreement, and registration rights. The document includes detailed information about financing activities, such as the issuance of convertible debentures, terms of conversion, redemption rights, and related agreements. It is not an annual or quarterly report, earnings release, or management discussion. It is not a proxy, voting result, or governance document. The primary content is about a material definitive agreement related to financing and capital structure changes. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed substantive information, not just an announcement or summary, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2023-04-11 English
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Scilex Holding Company. It details the entry into a material definitive agreement involving convertible debentures, including terms of the second convertible debenture issued on April 11, 2023. The document includes a summary of the agreement, terms of the convertible debenture, and references to related filings such as Form S-1 registration statements. It is not a full financial report, earnings release, or annual/interim report, but rather a regulatory filing disclosing a material event related to financing and securities issuance. The document is lengthy (15,000 characters) and contains detailed information about the financing transaction, but it is primarily a regulatory disclosure of a material definitive agreement and related securities issuance. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-04-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.